Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
API-FOOT: Ropivacaine Infusion Methods for Post-Foot/Ankle Surgery Pain
NCT03372304Phase 4Completed
- Sponsor
- Nordsjællands Hospital
- Start
- Nov 2017
- Primary completion
- Feb 2019
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
A Phase 4 trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain, sponsored by Nordsjællands Hospital. Started Nov 2017; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03372304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03372304.